Clinical Epigenetics (Nov 2023)
Retraction Note: Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelialmesenchymal transition, migration, and on the pro-inflammatory phenotype
- Giulia Stazi,
- Ludovica Taglieri,
- Alice Nicolai,
- Annalisa Romanelli,
- Rossella Fioravanti,
- Stefania Morrone,
- Manuela Sabatino,
- Rino Ragno,
- Samanta Taurone,
- Marcella Nebbioso,
- Raffaella Carletti,
- Marco Artico,
- Sergio Valente,
- Susanna Scarpa,
- Antonello Mai
Affiliations
- Giulia Stazi
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- Ludovica Taglieri
- Department of Experimental Medicine, Sapienza University of Rome
- Alice Nicolai
- Department of Experimental Medicine, Sapienza University of Rome
- Annalisa Romanelli
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- Rossella Fioravanti
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- Stefania Morrone
- Department of Experimental Medicine, Sapienza University of Rome
- Manuela Sabatino
- Alchemical Dynamics s.r.l
- Rino Ragno
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- Samanta Taurone
- Department of Sense Organs, Sapienza University of Rome
- Marcella Nebbioso
- Department of Sense Organs, Sapienza University of Rome
- Raffaella Carletti
- Department of Radiologic, Oncological, and Anatomical and Pathological Sciences, Sapienza University of Rome
- Marco Artico
- Department of Sense Organs, Sapienza University of Rome
- Sergio Valente
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- Susanna Scarpa
- Department of Experimental Medicine, Sapienza University of Rome
- Antonello Mai
- Department of Chemistry and Technologies of Drugs, Sapienza University of Rome
- DOI
- https://doi.org/10.1186/s13148-023-01595-6
- Journal volume & issue
-
Vol. 15,
no. 1
pp. 1 – 2
Abstract
No abstracts available.